Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
Response to speculation
+Undoctored
Response to speculation
Wednesday 29 September 2021, 04:39 PM
Green Cross Health refers to speculation in the Australian media about its participation in a process to acquire Tamaki Health. Green Cross Health advises that it is working with Pacific Equity Partners (PEP) in that process, as the media speculates. The process is in its early stages.
The nature and terms of any transaction for the acquisition of Tamaki Health have yet to be determined. There is no certainty that Green Cross Health will be the successful party or that any transaction will be concluded.
Green Cross Health confirms it is in compliance with its continuous disclosure obligations.